TP53 and non-small cell lung carcinoma: The downregulation of ribosomal protein L4 (RPL4) inhibits the development of NSCLC cells by disrupting the MDM2-P53 pathway and altering PARP1/Snail/cyclin D1 expression with lead to apoptosis, invasion inhibition, and G1-phase arrest.